Does PEMBROLIZUMAB Cause Dermatitis contact? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Dermatitis contact have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.0% of all adverse event reports for PEMBROLIZUMAB.
12
Reports of Dermatitis contact with PEMBROLIZUMAB
0.0%
of all PEMBROLIZUMAB reports
1
Deaths
5
Hospitalizations
How Dangerous Is Dermatitis contact From PEMBROLIZUMAB?
Of the 12 reports, 1 (8.3%) resulted in death, 5 (41.7%) required hospitalization, and 1 (8.3%) were considered life-threatening.
Is Dermatitis contact Listed in the Official Label?
Yes, Dermatitis contact is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Dermatitis contact?
TREPROSTINIL (1,834)
DUPILUMAB (358)
HUMAN IMMUNOGLOBULIN G (345)
ADALIMUMAB (321)
EPOPROSTENOL (190)
ETANERCEPT (170)
NICOTINE (163)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (160)
AMBRISENTAN (147)
CHLORHEXIDINE\ISOPROPYL ALCOHOL (146)
Which PEMBROLIZUMAB Alternatives Have Lower Dermatitis contact Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G